Dr Esther Chan is a Senior Consultant in the Division of Haematology at the National University Cancer Institute, Singapore (NCIS) and Ng Teng Fong General Hospital, with a subspecialty focus on cellular therapy, lymphoma, and leukaemia. She obtained her medical degree from the National University of Singapore, and completed her specialist training in haematology, earning further accreditation from the Royal College of Physicians (UK) and FRCPath (Haematology).
Dr Chan leads and co-leads several international and local clinical trials in lymphoma and CAR-T cell therapies, with a strong research focus on cellular therapy, immunotherapy, and lymphoma biology.
As the Clinical Medical Director of the NUHS Adult Cellular Therapy Program and Clinical Lead of the NUH Lymphoma Group, Dr Chan is deeply committed to advancing safe, effective, and innovative care for patients with blood cancers.
